Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ff8a7b66-9202-4403-ae4b-d81ace17c7ef&Preview=1
Date 10/27/2010
Company Name Nellix
Mailing Address 2465-B Faber Place Palo Alto, CA 94303
Company Description Nellix has developed a revolutionary, percutaneously deliverable endograft for the treatment of Abdominal Aortic Aneurysms and Thoracic Aortic Aneurysms. This aortic endograft device and treatment fills the aneurysm, providing a highly stable and durable seal. The novel technology enables treatment of all aortic aneurysms and provides a distinct advantage over current therapies.
M&A Terms Endologix has acquired venture-backed medical device company Nellix Endovascular for $15 million in stock, plus additional milestone-based stock payments totaling as much as $39 million. As part of the acquisition, Nellix’s majority investor, Essex Woodlands Health Ventures, will also invest $15 million in the newly combined company.